| Today's Top Story |  |  | | - U.S. weighs response to India court decision against drug patent
The U.S. Trade Representative's office is reviewing the Indian Supreme Court's drug patent ruling. The agency could address the verdict in its yearly report on intellectual property rights protections, which is expected this month. India has previously been on the report's "priority watch list." The U.S.-India Business Council noted that "over 40 countries including China, Russia and Taiwan have already granted a patent for Novartis' Glivec, and India now stands out as unique for not granting a patent to this incremental innovation." Reuters (4/3)       | Health Care & Policy | | | | | Company & Financial News | | | | | Food & Agriculture | | | | - Biotech rider only codifies existing case law, USDA practice
 Activist claims that the Farmer Assurance Provision rider was passed to protect biotech-seed makers has no basis because the provision recognizes existing practices at the Department of Agriculture and a 2010 Supreme Court decision that prevented lower courts from automatically banning biotech crops when there are technical obstacles to an existing approval, Ag Professional editor Rich Keller writes. "In the five NEPA lawsuits against biotech crop approvals filed to date, not a single harm to consumers or the environment were even alleged, let alone proved. So, activist claims that the rider lets USDA ignore a court finding of environmental harm are patently false," said Gregory Conko of the Competitive Enterprise Institute. Ag Professional online (4/1) | Industrial & Environmental | | | | - Energy Department study highlights benefits of RFS
A study by researchers at the Department of Energy's Oak Ridge National Laboratory found that the Renewable Fuel Standard is good for the U.S., and its benefits will become more pronounced by 2022, when the share of biofuels in the transport sector is expected to top 36 billion gallons, writes Bob Dinneen, president and CEO of the Renewable Fuels Association. The study, which was published in the journal Biofuels, determined that increased use of biofuels will drive down fuel costs by 3% in 2015 and about 7% by 2022, Dinneen states. If the RFS is allowed to continue as designed, livestock, poultry and dairy costs will "remain stable or even decrease in some years" through 2030, Dinneen notes. EthanolProducer.com (4/1) | News from BIO | | | | - Evidence, Coverage and Incentives: A PMC/BIO Solutions Summit
BIO and the Personalized Medicine Coalition have partnered to bring together all stakeholders to discuss potential solutions to advance personalized medicine on April 17 in Washington, D.C. A key focus of the summit is a determination of the nature and level of evidence necessary to make reliable and appropriate decisions on the coverage, regulation and adoption of personalized medicine products. Other topics to be addressed are market access issues for companion diagnostics and incentives for the development of personalized medicine products. Learn more and register.
| SmartQuote | | | |  | Hold on; hold fast; hold out. Patience is genius."
--Georges-Louis Leclerc,
French naturalist, mathematician, cosmologist and author  |
| | This SmartBrief was created for jmabs1@gmail.com
| | | Read more at SmartBrief.com | | A powerful website for SmartBrief readers including: | | | | | | | | | | Recent BIO SmartBrief Issues: - Tuesday, April 02, 2013
- Monday, April 01, 2013
- Friday, March 29, 2013
- Thursday, March 28, 2013
- Wednesday, March 27, 2013
| | | Lead Editor: Tom Parks
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004 | | | | | | © 1999-2013 SmartBrief, Inc.® Legal Information |
|
No comments:
Post a Comment